Assignee
UNIV OF NORTH TEXAS HEALTH SCIENCE CENTER
US·10 granted patents·11 pending applications·6 citations·filing 2014–2025
Top patents by PatentIndex Score
21 records- 0179US9612245B2Multiple-pulse pumping for enhanced fluorescence detection and molecular imaging in cells and tissueUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2014·Granted Apr 4, 2017·5 cites·47 claims
- 0268US2023357737A1Engineered cas9 variantsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2023·Application pending·0 cites
- 0364US9555011B2Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeuticsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2015·Granted Jan 31, 2017·1 cites·7 claims
- 0464US2024016828A1Inhibition of ngly1 for the treatment of cancerUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2023·Application pending·0 cites
- 0562US11230711B2Inhibition of LET7I as a means to enhance the protective effect of progesterone against strokeUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Granted Jan 25, 2022·0 cites·7 claims
- 0661US2022135975A1Inhibition of let7i as a means to enhance the protective effect of progesterone against strokeUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2022·Application pending·0 cites
- 0756US12234228B2Nitric oxide donor and anti-oxidant compoundsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2019·Granted Feb 25, 2025·0 cites·78 claims
- 0855US12208146B2Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereofUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2019·Granted Jan 28, 2025·0 cites·23 claims
- 0953US11779592B2Inhibition of NGLY1 for the treatment of cancerUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Granted Oct 10, 2023·0 cites·11 claims
- 1052US11713452B2Engineered CAS9 variantsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Granted Aug 1, 2023·0 cites·16 claims
- 1152US2024173256A1Hdl mimicking targeted drug delivery system for the treatment of solid tumorsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2023·Application pending·0 cites
- 1252US2017333563A1Drug delivery vehicleUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2017·Application pending·0 cites
- 1352US2025333401A1Nitric oxide donor and anti-oxidant compoundsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2025·Application pending·0 cites
- 1446US12377065B2Compositions for treatment of substance use disorderUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2020·Granted Aug 5, 2025·0 cites·22 claims
- 1543US2022008350A1Process for engineering targeted nanoparticlesUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2019·Application pending·0 cites
- 1642US2017165200A1Composition of lipid-based nanoparticles for small molecules and macromoleculesUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2016·Application pending·0 cites
- 1742US2017112775A1Situ self-assembling pro-nanoparticle compositions and methods of preparation and use thereofUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2016·Application pending·0 cites
- 1841US11111303B2Compositions and methods for activation of NK cells killing of prostate cancer and breast cancer cellsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Granted Sep 7, 2021·0 cites·22 claims
- 1940US2020138727A1Enhanced therapeutic agent and nucleic acid delivery via hdl or reconstituted hdl nanoparticlesUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Application pending·0 cites
- 2038US11678658B2Devices, systems, and methods for modeling ocular translaminar pressure gradientsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2019·Granted Jun 20, 2023·0 cites·20 claims
- 2129US2021139844A1Reprogramming fibroblasts to retinal cellsUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when UNIV OF NORTH TEXAS HEALTH SCIENCE CENTER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →